MAK Capital Fund reported a 12.6% stake in ADS shares of Autolus Therapeutics AUTL · 33,621,487 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 12.6%
Last report: 11.3% · filed 26/02/13
Shares held: 33,621,487 sh
Class: Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
Stock: Autolus Therapeutics AUTL
Holder: MAK Capital Fund
Event date: 26/03/31
Filed: 26/05/15

12.6% stake · +1.3pp from the last report

Stake: 12.6%
Last report: 11.3%
Since last report: +1.3pp

Autolus Therapeutics trades, last 26 weeks

What else happened in Autolus Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

MAK Capital Fund's other 5% stake reports

MAK Capital Fund
5% stakeComstock
5% stake
Comstock
LODE
6.7% stake
5,065,656 sh
6.7% stake
Filed 09/16
MAK Capital Fund
5% stakeStandard Biotools
5% stake
Standard Biotools
LAB
6.7% stake
26,172,626 sh
6.7% stake
Filed 05/15
MAK Capital Fund
5% stakeEvotec
5% stake
Evotec
EVO
7.1% stake
12,681,898 sh
7.1% stake
Filed 05/01
MAK Capital Fund
5% stakeEvotec
5% stake
Evotec
EVO
7% stake
12,503,512 sh
7% stake
Filed 04/06
MAK Capital Fund
5% stakeEvotec
5% stake
Evotec
EVO
7% stake
12,503,512 sh
7% stake
Filed 03/30

MAK Capital Fund reported a 12.6% stake in ADS shares of Autolus Therapeutics AUTL · 33,621,487 sh · amendment · passive holder | Whalegun